These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 37933858)
1. A Bioorthogonal Decaging Chemistry of Yan Z; Pan Y; Jiao G; Xu M; Fan D; Hu Z; Wu J; Chen T; Liu M; Bao X; Ke H; Ji X J Am Chem Soc; 2023 Nov; 145(45):24698-24706. PubMed ID: 37933858 [TBL] [Abstract][Full Text] [Related]
2. A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry. Dong Y; Tu Y; Wang K; Xu C; Yuan Y; Wang J Angew Chem Int Ed Engl; 2020 Apr; 59(18):7168-7172. PubMed ID: 32003112 [TBL] [Abstract][Full Text] [Related]
3. On-Demand Activation of a Bioorthogonal Prodrug of SN-38 with Fast Reaction Kinetics and High Releasing Efficiency Zhou Z; Feng S; Zhou J; Ji X; Long YQ J Med Chem; 2022 Jan; 65(1):333-342. PubMed ID: 34963283 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic Evaluation of Bioorthogonal Decaging with trans-Cyclooctene: The Effect of Fluorine Substituents on Aryl Azide Reactivity and Decaging from the 1,2,3-Triazoline. Matikonda SS; Fairhall JM; Fiedler F; Sanhajariya S; Tucker RAJ; Hook S; Garden AL; Gamble AB Bioconjug Chem; 2018 Feb; 29(2):324-334. PubMed ID: 29327914 [TBL] [Abstract][Full Text] [Related]
5. Click and Release: A High-Content Bioorthogonal Prodrug with Multiple Outputs. Ji X; Aghoghovbia RE; De La Cruz LKC; Pan Z; Yang X; Yu B; Wang B Org Lett; 2019 May; 21(10):3649-3652. PubMed ID: 31063383 [TBL] [Abstract][Full Text] [Related]
7. Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting. Stefan N; Zimmermann M; Simon M; Zangemeister-Wittke U; Plückthun A Bioconjug Chem; 2014 Dec; 25(12):2144-56. PubMed ID: 25350699 [TBL] [Abstract][Full Text] [Related]
8. Fast Cyclization of a Proline-Derived Self-Immolative Spacer Improves the Efficacy of Carbamate Prodrugs. Dal Corso A; Borlandelli V; Corno C; Perego P; Belvisi L; Pignataro L; Gennari C Angew Chem Int Ed Engl; 2020 Mar; 59(10):4176-4181. PubMed ID: 31881115 [TBL] [Abstract][Full Text] [Related]
9. A new cyclopamine glucuronide prodrug with improved kinetics of drug release. Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246 [TBL] [Abstract][Full Text] [Related]
10. General Strategy for Integrated Bioorthogonal Prodrugs: Pt(II)-Triggered Depropargylation Enables Controllable Drug Activation Sun T; Lv T; Wu J; Zhu M; Fei Y; Zhu J; Zhang Y; Huang Z J Med Chem; 2020 Nov; 63(22):13899-13912. PubMed ID: 33141588 [TBL] [Abstract][Full Text] [Related]
11. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation. Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257 [TBL] [Abstract][Full Text] [Related]
12. Development of a self-immolative linker for tetrazine-triggered release of alcohols in cells. Davies S; Oliveira BL; Bernardes GJL Org Biomol Chem; 2019 Jun; 17(23):5725-5730. PubMed ID: 31135016 [TBL] [Abstract][Full Text] [Related]
13. A minimally-masked inactive prodrug of panobinostat that is bioorthogonally activated by gold chemistry. Rubio-Ruiz B; Pérez-López AM; Sebastián V; Unciti-Broceta A Bioorg Med Chem; 2021 Jul; 41():116217. PubMed ID: 34022529 [TBL] [Abstract][Full Text] [Related]
14. Selective activation of prodrugs in breast cancer using metabolic glycoengineering and the tetrazine ligation bioorthogonal reaction. Mitry MMA; Dallas ML; Boateng SY; Greco F; Osborn HMI Bioorg Chem; 2024 Jun; 147():107304. PubMed ID: 38643563 [TBL] [Abstract][Full Text] [Related]
16. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier. Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251 [TBL] [Abstract][Full Text] [Related]